OPKO Health Share Holder Equity 2010-2024 | OPK

OPKO Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
OPKO Health Annual Share Holder Equity
(Millions of US $)
2023 $1,389
2022 $1,562
2021 $1,685
2020 $1,672
2019 $1,615
2018 $1,791
2017 $1,844
2016 $2,092
2015 $1,980
2014 $836
2013 $873
2012 $179
2011 $161
2010 $23
2009 $32
OPKO Health Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $1,403
2024-06-30 $1,395
2024-03-31 $1,253
2023-12-31 $1,389
2023-09-30 $1,445
2023-06-30 $1,535
2023-03-31 $1,552
2022-12-31 $1,562
2022-09-30 $1,629
2022-06-30 $1,719
2022-03-31 $1,615
2021-12-31 $1,685
2021-09-30 $1,766
2021-06-30 $1,743
2021-03-31 $1,697
2020-12-31 $1,672
2020-09-30 $1,624
2020-06-30 $1,588
2020-03-31 $1,549
2019-12-31 $1,615
2019-09-30 $1,642
2019-06-30 $1,709
2019-03-31 $1,763
2018-12-31 $1,791
2018-09-30 $1,789
2018-06-30 $1,810
2018-03-31 $1,823
2017-12-31 $1,844
2017-09-30 $2,089
2017-06-30 $2,107
2017-03-31 $2,107
2016-12-31 $2,092
2016-09-30 $2,105
2016-06-30 $2,016
2016-03-31 $1,998
2015-12-31 $1,980
2015-09-30 $1,969
2015-06-30 $827
2015-03-31 $813
2014-12-31 $836
2014-09-30 $887
2014-06-30 $913
2014-03-31 $831
2013-12-31 $873
2013-09-30 $868
2013-06-30 $312
2013-03-31 $320
2012-12-31 $179
2012-09-30 $146
2012-06-30 $152
2012-03-31 $155
2011-12-31 $161
2011-09-30 $102
2011-06-30 $111
2011-03-31 $124
2010-12-31 $23
2010-09-30 $20
2010-06-30 $50
2010-03-31 $56
2009-12-31 $32
2009-09-30 $64
2009-06-30 $39
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.078B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $196.322B 23.95
Intuitive Surgical (ISRG) United States $195.140B 102.02
Alcon (ALC) Switzerland $42.414B 28.38
Edwards Lifesciences (EW) United States $41.569B 26.40
IQVIA Holdings (IQV) United States $36.630B 20.18
IDEXX Laboratories (IDXX) United States $34.166B 40.24
DexCom (DXCM) United States $28.447B 42.84
Waters (WAT) United States $22.175B 32.79
STERIS (STE) Ireland $21.157B 24.36
SONOVA HOLDING (SONVY) Switzerland $20.795B 0.00
Hologic (HOLX) United States $18.343B 19.35
Fresenius Medical Care AG KGaA (FMS) Germany $13.004B 13.35
Sysmex ADR (SSMXY) Japan $12.946B 0.00
Globus Medical (GMED) United States $11.536B 29.21
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.260B 44.81
Teleflex (TFX) United States $8.904B 14.20
Glaukos (GKOS) United States $7.940B 0.00
PROCEPT BioRobotics (PRCT) United States $4.884B 0.00
Integer Holdings (ITGR) United States $4.632B 26.26
Veracyte (VCYT) United States $3.068B 92.07
Inari Medical (NARI) United States $2.907B 0.00
LivaNova (LIVN) United Kingdom $2.787B 16.09
TransMedics (TMDX) United States $2.552B 80.89
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.167B 17.66
Tandem Diabetes Care (TNDM) United States $2.023B 0.00
Integra LifeSciences Holdings (IART) United States $1.820B 9.51
RxSight (RXST) United States $1.807B 0.00
Alphatec Holdings (ATEC) United States $1.427B 0.00
Artivion (AORT) United States $1.185B 78.53
Pulse Biosciences (PLSE) United States $1.088B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 14.53
Paragon 28 (FNA) United States $0.841B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.723B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.638B 0.00
Mesa Laboratories (MLAB) United States $0.593B 13.97
AxoGen (AXGN) United States $0.587B 0.00
SiBone (SIBN) United States $0.527B 0.00
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.488B 0.00
Semler Scientific (SMLR) United States $0.463B 31.05
Tactile Systems Technology (TCMD) United States $0.428B 23.18
CVRx (CVRX) United States $0.360B 0.00
ClearPoint Neuro (CLPT) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.312B 0.00
NeuroPace (NPCE) United States $0.290B 0.00
AngioDynamics (ANGO) United States $0.278B 0.00
Inogen (INGN) United States $0.223B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
Accuray (ARAY) United States $0.194B 0.00
Nevro (NVRO) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.60
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Neuronetics (STIM) United States $0.027B 0.00
NexGel (NXGL) United States $0.023B 0.00
Spectral AI (MDAI) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00